Physical functional dimension scales are an alternative to condition-specific health status measures

Physikalische Medizin Rehabilitationsmedizin Kurortmedizin

Volumn 10, Issue 6, 2000, Pages 212-216

  Ryser, L ^a   Aeschlimann, A ^b   Sangha, O ^c   Michel, B A ^a   Stucki, G ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Zurzach Rheumatology and Rehabilitation Clinic   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Factor analysis; Osteoarthritis; Outcome assessment; WOMAC

Indexed keywords

CHONDROITIN SULFATE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; HEALTH STATUS; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; OSTEOARTHRITIS; PHYSICAL CAPACITY; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; STANDING; TASK PERFORMANCE; TREATMENT OUTCOME; VALIDATION PROCESS; WALKING;

EID: 0034536694     PISSN: 09406689     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1061770     Document Type: Article

References (17)

1. Therapeutic targets in osteoarthritis
2. Outcome measurement in osteoarthritis clinical trials
3. Generic and disease-specific measures in assessing health status and quality of life
4. The MOS 36-item short-form health survey (SF-36). 1. Conceptual framework and item selection
5. The sort form-36 is preferable to the SIP as a generic health status measure in patients undergoing elective total hip arthroplasty
6. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III
7. The OMERACT filter for outcome measures in rheumatology
8. A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee
9. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee
10. Pain assessment in osteoarthritis: Experience with the WOMAC osteoarthritis index
11. Signal measurement strategies: Are they feasible and do they offer any advantage in outcome measurement in osteoarthritis?
12. Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): Post validation reapplication of the WOMAC osteoarthritis index
13. Instruments to assess osteoarthritis - Current status and future needs
14. Evaluation einer deutschen version des WOMAC (Western Ontario und McMaster Universities) arthroseindex
15. A new look at the Western Ontario and McMaster Universities osteoarthritis index using rasch analysis